CNBC April 11, 2023
Meg Tirrell

Key Points

– In an interview with CNBC, Dr. Robert Califf said better regulation is needed to combat health misinformation that’s rampant online.

– He also said the agency, though it has no direct role in drug pricing, will use its bully pulpit more.

– New obesity drugs bring “great hope,” Califf said, but need more data.

Life expectancy in the U.S. is between three and five years lower than the average in other high-income countries — and the gap comes in part from misinformation, Food and Drug Administration Commissioner Dr. Robert Califf said.

“It’s looking worse, not better, over the last several years,” Califf told CNBC in an interview Thursday at the agency’s headquarters in Silver Spring, Maryland.

It’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Healthcare System, Interview / Q&A, Patient / Consumer, Provider, Trends
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices

Share This Article